The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miranda, M. E.
Right arrow Articles by Buyon, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miranda, M. E.
Right arrow Articles by Buyon, J. P.
The Journal of Immunology, 1998, 161: 5061-5069.
Copyright © 1998 by The American Association of Immunologists

Accessibility of SSA/Ro and SSB/La Antigens to Maternal Autoantibodies in Apoptotic Human Fetal Cardiac Myocytes1

M. Eugenia Miranda*, Chung-E Tseng*, William Rashbaum{dagger}, Robert L. Ochs{ddagger}, Carlos A. Casiano{ddagger}, Francis Di Donato*, Edward K. L. Chan{ddagger} and Jill P. Buyon2,*

* Hospital for Joint Diseases, New York University School of Medicine, New York, NY 10003; {dagger} Department of Obstetrics and Gynecology, Beth Israel Medical Center, New York, NY 10003; and {ddagger} The Scripps Research Institute, La Jolla, CA 92037


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Access of intracellular Ags SSA/Ro and SSB/La to cognate maternal autoantibodies is unexplained despite their strong association with congenital heart block. To investigate the hypothesis that apoptosis facilitates surface accessibility of these Ags, human fetal cardiac myocytes from 16- to 22-wk abortuses were established in culture using a novel technique in which cells were isolated after perfusing the aorta with collagenase. Confirmation of cardiac myocytes included positive staining with antisarcomeric {alpha}-actinin and contractility induced by 1.8 mM calcium. Incubation with 0.5 µM staurosporine or 0.3 mM 2,3-dimethoxy-1,4-naphthoquinone induced the characteristic morphologic and biochemical changes of apoptosis. The cellular topology of Ro and La was evaluated with confocal microscopy and determined in nonapoptotic and apoptotic cardiocytes by indirect immunofluorescence. In permeabilized nonapoptotic cardiocytes, Ro and La were predominantly nuclear, and propidium iodide (PI) stained the nucleus. In early apoptotic cardiocytes, condensation of the PI- and Ro- or La-stained nucleus was observed, accompanied by Ro/La fluorescence around the cell periphery. In later stages of apoptosis, nuclear Ro and La staining became weaker, and PI demonstrated nuclear fragmentation. Ro/La-stained blebs emerged from the cell membrane, a finding observed in nonpermeabilized cells, supporting an Ab-Ag interaction at the cell surface. In summary, induction of apoptosis in cultured cardiocytes results in surface translocation of Ro/La and recognition by Abs. Although apoptotic cells are programmed to die and do not characteristically evoke inflammation, binding of maternal Abs and subsequent influx of leukocytes could damage surrounding healthy fetal cardiocytes.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
One of the central questions in systemic autoimmunity is whether autoantibodies are directly responsible for tissue injury. Over three decades ago, it was noted that mothers who gave birth to children with congenital heart block (CHB)3 often had autoimmune diseases (1, 2). It is now well established that heart block detected before or at birth, in the absence of structural abnormalities, is strongly associated with maternal autoantibodies to SSA/Ro and/or SSB/La ribonucleoproteins, independent of whether the mother has systemic lupus erythematosus, Sjögren’s syndrome, or is totally asymptomatic (3, 4). Damage to the conducting system and myocardium occurs in a previously normal fetus and is presumed to arise from the transplacental passage of these maternal IgG autoantibodies (5). Autoimmune-associated CHB does not occur randomly during fetal development, but rather is most often detected between 16 and 24 wk of gestation (6, 7). In some cases, there may be an associated myocarditis (8, 9). Although varying degrees of block can occur, third degree block is irreversible and carries a substantial mortality (approaching 30%) and morbidity, with more than 60% of affected children requiring lifelong pacemakers (7). Despite exposure to the identical circulating Abs, the maternal heart is never affected.

The candidate Ags and their cognate Abs have been characterized extensively at the molecular level. Initial cloning of 60-kDa SSA/Ro identified a zinc finger and an RNA-binding protein consensus motif (10, 11), both of which could account for its direct interaction with small cytoplasmic hY-RNAs (12). It has been suggested recently that 60-kDa SSA/Ro may function as part of a novel quality control or discard pathway for 5S rRNA production in Xenopus oocytes (13). Anti-SSB/La Abs recognize a 48-kDa polypeptide that does not share antigenic determinants with either 52- or 60-kDa SSA/Ro (14, 15). SSB/La directly binds a spectrum of RNAs and associates at least transiently with 60-kDa SSA/Ro (16). It facilitates maturation of RNA polymerase III transcripts (17), and has recently been shown to be required for 3'-endonucleolytic cleavage that matures tRNA yeast precursors (18). In addition to the well-characterized 60-kDa SSA/Ro and 48-kDa SSB/La autoantigens, another target of the autoimmune response in mothers whose children have CHB is the 52-kDa SSA/Ro protein (19). The full-length protein, 52{alpha}, has three distinct domains: an N-terminal region rich in cysteine/histidine motifs containing two distinct zinc fingers known as RING finger and B-box; a central region containing two coiled coils with heptad periodicity, one being a leucine zipper, both with potential for intermolecular dimerization; and a C-terminal "rfp-like" domain (20, 21). We have recently described an alternative 52 mRNA transcript derived from the splicing of exon 4 encoding amino acids 168–245 inclusive of the leucine zipper, which results in a smaller protein, 52ß, with a predicted m.w. of 45 kDa (22). This isoform is maximally expressed in the human fetal heart between 14 and 16 wk of gestation.

Despite new insights into pathogenic mechanisms of autoantibodies (23, 24, 25), an explanation of how maternal autoantibodies directly interact with intracellular Ags is not apparent, raising the possibility that they are clinical markers and not truly causal. However, in two studies of fatal CHB, culpable footprints were described: in one, maternal IgG bearing anti-SSB/La Ids was demonstrated on the surface of the fetal myocardial fibers (26); in another, anti-SSA/Ro Abs were eluted from the affected fetal heart (27). Apoptosis has been proposed as a means of presenting otherwise sequestered Ags to the immune system (28). Applicability of apoptosis to the pathogenesis of CHB is supported by several observations. It is a selective process of physiologic cell deletion in embryogenesis and normal tissue turnover, plays an important role in shaping morphologic and functional maturity (29, 30), and affects scattered single cells rather than tracts of contiguous cells (31). Therefore, Ab binding to apoptotic cells could trigger an inflammatory response that damages surrounding healthy tissue. Casciola-Rosen et al. have demonstrated the clustering of SSA/Ro and SSB/La in apoptotic blebs on the surface of apoptotic keratinocytes (28).

To investigate the hypothesis that apoptosis facilitates accessibility of SSA/Ro and SSB/La in the heart to circulating maternal autoantibodies, a reliable system for culturing human fetal cardiac myocytes was first established. Apoptosis was then readily induced with either staurosporine or DMNQ, and cellular topology of SSA/Ro and SSB/La was evaluated by indirect immunofluorescence.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Isolation and culture of human fetal heart cells

Human fetal hearts are aseptically obtained after elective termination of normal pregnancy by dilatation and evacuation. This is done in accordance with the guidelines of the Institutional Review Board and after obtaining consent from the mothers. No cardiac toxic drugs are administered to the mothers during these procedures. Gestational age is defined by sonographic measurement of biparietal diameter and femur length. The hearts, weighing 3 to 5 g each, are immediately dissected from the thoracic cavity with the great vessels intact and transported to our laboratory within 15 min on iced HBSS minus calcium and magnesium (Life Technologies, Gaithersburg, MD) containing 100 U/ml of heparin.

The aorta is cannulated for continuous perfusion of the coronary arteries with calcium-free Tyrode’s solution (117 mM NaCl, 5.7 mM KCl, 11 mM glucose, 4.4 mM NaHCO3, 1.5 mM KH2PO4, 1.7 mM MgCl2, and 20 mM HEPES, pH 7.4) containing 1 U/ml of Na-Heparin at 37°C, bubbled with 100% O2, as described for the Langendorff preparation (32). After 15 min of washing to clear the blood from the heart, fresh calcium-free Tyrode’s solution containing 1.5 mg/ml collagenase A (type III) is recirculated for approximately 20 min. The heart initially becomes completely pale and flaccid, and subsequently dissociates spontaneously, allowing cells to slowly drip and fall on a petri dish containing 0.25% trypsin, 1 mM EDTA in HBSS. At this point, clumps of cells are gently dissociated with forceps, and the resulting cell suspension is poured over a cell strainer, composed of 70-µm nylon mesh (Fischer, Pittsburgh, PA). Cells are centrifuged to remove the trypsin, and the pellet is resuspended in 20 ml of culture medium (DMEM supplemented with 10% FBS, 50 U/ml penicillin, 50 U/ml streptomycin, 100 mg/ml gentamicin, 1 mM nonessential amino acid (Life Technologies), 0.1 mM essential medium vitamins (Life Technologies), 2 mM glutamine, and 0.1 mM sodium pyruvate). To minimize fibroblast overgrowth of the cardiac cultures, preplating of the cells is done in culture medium for 20 min in 5% CO2 at 37°C. The nonadherent cells are then plated at approximately 3 x 106 cells/25-cm2 culture flask and grown in 5% CO2 at 37°C.

Cardiocyte contractility

To evaluate cell contractility and establish purity of the cardiocyte culture, medium containing 1.8 mM CaCl2 was added to the cultured cells on days 4 and 14. Flasks were maintained on a warmed microscope stage. Morphologic analysis was conducted using a Scientific Imaging Solutions workstation (BDS, Bethesda, MD) consisting of a Macintosh IIfx personal computer equipped with a Pixel Pipeline video acquisition board (Perceptics, Knoxville, TN), a video camera (CCD72; MTI, Fremont, CA), and TCL-image software (Oncre Imaging Systems, Rockville, MD). Backscattered electron images were acquired through the video camera directly from the screen of a high resolution image acquisition system, and projected onto a VCR-TV unit. Using the imaging workstation, the gray-scale images were adjusted for contrast and brightness, and cells beating in culture could be observed and recorded.

Immunocytochemistry

On day 4 of culture, cells were harvested and transferred to Lab-Tek 4 chamber slides (7 x 105 cells/well). Twenty-four hours later, cells were washed in PBS containing 0.1 mM CaCl2 (PBS-C) for 5 min, fixed with 4% paraformaldehyde for 20 min, and permeabilized with 100% acetone for 5 min at room temperature. Cells were then washed for 5 min in PBS-C and incubated with monoclonal anti-{alpha}-actinin (sarcomeric) mouse IgG1 (Sigma, St. Louis, MO) at a dilution of 1/500 in PBS-C for 1 h. Monoclonal anti-{alpha}-actinin is specific for {alpha}-skeletal muscle actinin and {alpha}-cardiac muscle actinin. It stains Z lines and dots in stress fibers of skeletal and cardiac muscle, but not in nonsarcomeric muscle elements such as connective tissue, epithelium, nerves, or smooth muscle. Cells were again washed for 5 min with PBS-C and incubated with anti-mouse IgG (whole molecule) FITC conjugate at 1/500 dilution in PBS-C for 30 min. After extensive washing for 5 min, the cells were mounted in Vectashield (Vector Laboratories, Burlingame, CA).

Induction of apoptosis

On the third day after isolation, cardiac myocytes were harvested and transferred to eight-well chamber slides. Twenty-four hours later, various concentrations of staurosporine (Sigma) (0.5, 0.8, 1, 1.2 µM) or 2,3-dimethoxy-1,4-naphthoquinone (DMNQ, a gift from Dr. Gerald Cohen, Medical Research Council, Toxicology Unit, Leicester, U.K.) (0.03, 0.3, 3 mM) were added to the culture medium; subsequently, cells were incubated in 5% CO2 at 37°C. The morphology was assessed every hour by phase-contrast light microscopy and fluorescence microscopy (propidium iodide (PI) staining).

Assessment of apoptosis

The morphologic characteristics of apoptosis were assessed by phase-contrast light microscopy, trypan blue exclusion, and fluorescence microscopy (PI staining) (33). For electron microscopy, cells were processed as described (34, 35). DNA from whole cell populations was extracted, processed, and electrophoresed on 1.5% agarose gels (33). Cleavage of poly(ADP-ribose) polymerase (PARP) was detected in immunoblot of cell lysates (36) using a highly specific human antiserum (37).

Cellular topology of SSA/Ro and SSB/La in nonapoptotic and apoptotic cardiocytes

Human sera. To evaluate the cellular localization of SSA/Ro and SSB/La, cells were incubated with one of the following antisera at a dilution of 1/100 for 1 h in PBS-C: human autoimmune serum containing 48-kDa anti-SSB/La Abs alone, as evaluated by ELISA, immunoblot, and immunoprecipitation (Ze (38)); or anti-SSB/La Abs affinity purified from serum (Lew); or 52- and 60-kDa SSA/Ro Abs alone (Ge (20) or Ohl); or serum from a healthy multigravida with no known autoantibodies (Mo). In experiments in which cells were double labeled with monoclonal antisarcomeric {alpha}-actinin and human sera, the second-stage Ab used to detect SSA/Ro or SSB/La was goat anti-human IgG (whole molecule) Texas Red conjugate (Accurate Chemical, Westbury, NY).

Immunofluorescence. Apoptotic and control cells were double stained with human antisera, as described above, and with PI (33), to study simultaneously the redistribution of the Ags and the morphologic changes in the nucleus. Staining was performed in living as well as in fixed/permeabilized cells.

Cardiocytes were fixed with 4% paraformaldehyde in PBS, pH 7.4, for 20 min and permeabilized with 100% acetone for 5 min at room temperature before incubating with human serum (diluted 1/100 in PBS-C) for 1 h, followed by goat anti-human IgG (whole molecule) FITC conjugate (Sigma) for 30 min. PI (5 µg/ml) was then added for 5 min. Slides were mounted with Vectashield (Vector Laboratories). To study the surface expression of Ags on living cells, human antisera were added for 60 min at 37°C before fixation in 4% paraformaldehyde, followed by incubation with the fluorescein conjugate and PI.

Conventional immunofluorescence microscopy and photomicrography were conducted using an Axiophot microscope (Carl Zeiss, Thornwood, NY). A scanning laser confocal microscope system (model MultiProbe 20001; Molecular Dynamics, Sunnyvale, CA) was used to determine the cellular localization of the labeled Ags (39).


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Generation of human fetal cardiac myocyte cultures

Initial attempts to culture human cardiocytes employed mechanical mincing to facilitate enzymatic dispersion of tissue (40); however, the final cell yield was insufficient and extremely variable. Accordingly, a novel approach was developed employing a Langendorff apparatus with constant flow (32, 41). Perfusion of fetal hearts (16–22 wk) with collagenase in Ca2+-free Tyrode’s solution at 37°C resulted in complete loosening of the intercellular matrix and intercellular adhesion forces, leading to spontaneous dissociation of cells. Initial inspection of the dissociated fetal heart cells by phase-contrast light microscopy revealed a homogeneous population of rounded cells. After 24 h in culture on standard tissue culture-grade plasticware, the cells could be observed to adhere, and by day 3 a clear monolayer of 75 to 85% confluent cells was apparent. This method consistently yielded approximately 45 to 60 x 106 cells per 3 to 5 g fetal heart.

The purity of cultures was evaluated by the induction of contractility. On day 4 of culture, CaCl2 (1.8 mM) was added to the medium, and the cardiac myocytes were placed on a warmed stage to maintain the temperature at 37°C. The cells were viewed in an enhanced computer-generated image (x250). In the majority of fields, more than 90% of cells were observed to contract in synchrony at rates of 25 to 75 beats per minute. However, the number of beating cells per field became progressively fewer over time, with only isolated groups of beating cells at day 14.

Staining with monoclonal antisarcomeric {alpha}-actinin was done at day 4 of culture to further assess purity of the cells. At this time, approximately 90% of the plated cells displayed the expected striations characteristic of differentiated cardiac myocytes (Fig. 1Go). The percentage of cells expressing sarcomeric {alpha}-actinin decreased over time, and was only 10% after 14 days in culture. Although dedifferentiated cardiac myoblasts do not express contractile proteins and have the capacity to proliferate, the cells were considered to be cardiac fibroblasts because of their characteristic flat appearance and large nuclei (40).



View larger version (89K):
[in this window]
[in a new window]
 
FIGURE 1. Immunofluorescence staining of cultured human fetal cardiocytes. Cells were double labeled with antisarcomeric {alpha}-actinin, represented by green fluorescence, and human sera reactive with either SSB/La (A) or SSA/Ro (B), represented by red fluorescence. Cells were incubated at the same time with the murine mAb and human sera. After washing, the corresponding secondary Abs were added simultaneously. All of the cultured cells display the expected striations characteristic of differentiated cardiac myocytes. Note that contaminating fibroblasts would only demonstrate nuclear (red) fluorescence and no sarcomeric striations. Bar, 20 µm.

 
Induction and confirmation of apoptosis

Various concentrations of staurosporine (Sigma) (0.5, 0.8, 1, 1.2 µM) or DMNQ (0.03, 0.3, 3 mM) were tested, and it was established that the optimal concentrations required to induce apoptosis were 0.5 µM staurosporine and 0.3 mM DMNQ.

By phase-contrast microscopy, fluorescence microscopy of PI-stained cells, and electron microscopy, morphologic signs of early apoptosis were observed in 40% of the cardiocytes after 3 and 4 h of incubation with 0.5 µM staurosporine or 0.3 mM DMNQ, respectively; after 7 h, 97% of the cells showed signs of advanced apoptosis. Trypan blue exclusion indicated membrane integrity. Fluorescence microscopy of nonapoptotic cardiocytes showed strong nuclear and diffuse cytoplasmic staining with PI; the nucleus was large and ovoid, with a diameter of 16 to 24 µm. The cytoplasm was between 75 and 110 µm in length. During the initial stages of apoptosis, chromatin condensation could be appreciated, followed by shrinkage of the nucleus, which decreased to 5 to 8 µm before fragmenting. The cytoplasm also progressively decreased in size as blebs ranging from 1.3 to 5.2 µm emerged from the cell surface. Blebs tended to be larger in the later stages of apoptosis. Apoptotic cardiocytes were rounded and measured between 10 and 18 µm (Fig. 2Go).



View larger version (90K):
[in this window]
[in a new window]
 
FIGURE 2. Incubation of cultured human fetal cardiocytes with 0.5 µM staurosporine induces apoptosis. PI strongly stains the large ovoid nuclei in nonapoptotic cells (A). As expected, cytoplasmic staining is also present since no RNase was used (28). In B, apoptotic cardiocytes are rounded, the PI-stained nuclei are condensed or convoluted; in several areas, PI-stained blebs emerge from the cell surface. The total size of an apoptotic cell approximates that of the nucleus of a control cell. Bar, 20 µm.

 
Electron microscopy confirmed the typical changes of apoptosis. As shown in Figure 3GoB, 5 h after incubation with 0.5 µM staurosporine, shrinkage of the nucleus and formation of condensed chromatin could be seen. In later stages of apoptosis, the nucleus was highly condensed and the cytoplasm was fragmented (Fig. 3GoC). Agarose gel electrophoresis of cell lysates revealed the presence of a nucleosomal ladder in cells harvested 8 h after the addition of 0.5 µM staurosporine. Immunoblotting of cell lysates obtained from cultures incubated for 8 h with 0.5 µM staurosporine demonstrated cleavage of PARP yielding the characteristic 85-kDa fragment (Fig. 4Go).



View larger version (62K):
[in this window]
[in a new window]
 
FIGURE 3. Electron microscopy of apoptotic human fetal cardiocytes. In A are two nonapoptotic cardiocytes. In B, 5 h after incubation with 0.5 µM staurosporine, there is shrinkage of the nucleus and formation of condensed chromatin. In C, the nucleus is highly condensed with cytoplasmic fragmentation characteristic of the later stages of apoptosis.

 


View larger version (17K):
[in this window]
[in a new window]
 
FIGURE 4. Incubation of cultured human fetal cardiocytes with 0.5 µM staurosporine results in PARP cleavage. An immunoblot of cultured human fetal cardiocyte lysates demonstrates the presence of full-length 110-kDa PARP in nonapoptotic cardiocytes. At 5, 6, 7, and 8 h after the addition of staurosporine, an 85-kDa cleavage fragment, characteristic of apoptosis, is seen.

 
Cellular topology of SSA/Ro and SSB/La in nonapoptotic and apoptotic cardiocytes

Cultured human fetal cardiac myocytes were stained with human antisera and counterstained with PI to assess the nuclear morphology of nonapoptotic and apoptotic cells. In cultures from fetal hearts aged 16 to 22 wk, affinity-purified anti-SSB/La Ab and two sera (Ze (38) and Lew), each containing 48-kDa SSB/La Abs, demonstrated a homogeneous nuclear immunofluorescence pattern with marginally detectable green staining of the cytoplasm when applied individually to separate chambers of cardiocytes (Fig. 5GoA). Sera Ge (20) and Ohl, each containing anti-SSA/Ro Abs (52 and 60 kDa), also stained the nuclei, but demonstrated a stronger cytoplasmic signal than that observed for SSB/La (Fig. 5GoD). A normal human serum (Mo) did not stain nonapoptotic cardiocytes (Fig. 5GoG).



View larger version (112K):
[in this window]
[in a new window]
 
FIGURE 5. Cellular topology of SSA/Ro and SSB/La in permeabilized nonapoptotic and apoptotic cultured human fetal cardiocytes. Cells were double labeled with PI and antisera and observed under a confocal laser-scanning microscope. PI is seen as red fluorescence, SSA/Ro-SSB/La as green fluorescence, and overlapping pixels are orange-yellow. Anti-SSB/La stains the large nuclei in nonapoptotic cells; the strong green signal combined with PI staining of the nucleus is seen as yellow (A). In B, SSB/La is markedly decreased in the nucleus and increased in the cytoplasm of an apoptotic cardiocyte, while concentrating in blebs. In D, SSA/Ro is seen in the nucleus and cytoplasm of nonapoptotic cells; the combination of a moderately strong nuclear green signal with PI is seen as orange. In apoptotic cells, there is translocation of SSA/Ro to the cell periphery and strong staining of blebs (E). In G and H, normal human serum did not stain control or apoptotic cells, as evidenced by the absence of green fluorescence. PI shows the characteristic morphology of nonapoptotic and apoptotic cardiocytes. Low power views of permeabilized apoptotic cardiocytes stained with anti-SSB/La (C), anti-SSA/Ro (F), or normal human serum (I) are shown for reference. Images were taken 6 h after induction of apoptosis with 0.5 µM staurosporine. Bar, 15 µm (A, D, G) or 10 µm (B, E, H) or 40 µm (C, F, I).

 
Remarkable changes in the cellular topology of SSB/La and SSA/Ro were observed in the apoptotic cardiocytes. These results were the same, independent of whether the agent used to induce apoptosis was staurosporine or DMNQ. When cardiocytes were incubated for 6 h with 0.5 µM staurosporine, staining with anti-SSB/La was decreased in the apoptotic nucleus, but was increased in the cytoplasm and concentrated in blebs (Fig. 5Go, B and C). Similar redistribution of Ags was observed in apoptotic cardiocytes stained with anti-SSA/Ro (Fig. 5Go, E and F). SSA/Ro and SSB/La generally colocalized with PI in the surface blebs; however, this was not absolute, and occasional blebs appeared to be stained with PI exclusively or only with anti-SSB/La or SSA/Ro. In apoptotic cardiocytes stained with normal human serum, no immunofluorescent signal could be appreciated (Fig. 5Go, H and I). In several apoptotic cardiocytes, SSB/La was present in the cytoplasm and surface blebs, but was only marginally detected in the nucleus (Fig. 6Go). When cardiocytes were incubated for 7 h with 0.3 mM DMNQ, SSA/Ro localized predominantly in the periphery of the cells and in the apoptotic blebs (Fig. 7Go).



View larger version (44K):
[in this window]
[in a new window]
 
FIGURE 6. Topology of SSB/La in a permeabilized apoptotic human fetal cardiocyte. To more clearly demonstrate the redistribution of SSB/La during apoptosis, a three-dimensional composite of horizontal sections, taken from the same cell seen in Figure 5GoB, is shown. A shows staining with PI (red fluorescence), and B, 48-kDa SSB/La-FITC (green fluorescence); in C, red and green fluorescence are merged using confocal microscope software. The fragmentation of the PI-stained nucleus is best appreciated in A. In B, 48-kDa SSB/La is decreased in the nucleus and increased in the cytoplasm and blebs. Arrows point to surface blebs, which were confirmed by horizontal sections through the cell (data not shown). Bar, 10 µm.

 


View larger version (77K):
[in this window]
[in a new window]
 
FIGURE 7. Localization of SSA/Ro in permeabilized apoptotic human fetal cardiocytes. PI is seen as red fluorescence. In two separate images (A and B) taken 7 h after incubation with 0.3 mM DMNQ, the cytoplasmic staining with anti-SSA/Ro is markedly decreased compared with staining in the nonapoptotic cells, as seen in Figure 5GoD, and a rim of green fluorescence is seen in the periphery of the cells and apoptotic blebs (arrows). These changes are identical to those induced with staurosporine. Bar, 5 µm.

 
To further address the accessibility of autoantigens to maternal circulating autoantibodies, apoptotic cells were stained with human anti-SSB/La and SSA/Ro before fixation. As expected, SSB/La and SSA/Ro were not detected in the cytoplasm, nucleus, or on the cell surface of living nonapoptotic cardiocytes (Fig. 8Go, A and D). In contrast, both SSB/La and SSA/Ro were clearly present in the periphery and surface blebs of apoptotic cardiocytes (Fig. 8Go, B and C (SSB/La), E and F (SSA/Ro)). Normal human serum did not stain nonpermeabilized apoptotic cardiocytes, confirming that apoptosis does not render cells nonspecifically sticky (Fig. 8Go, H and I). Optical horizontal sections of nonpermeabilized apoptotic cardiocytes viewed by confocal microscopy (Z series) confirmed that anti-SSA/Ro stains the surface blebs, but not the nucleus or cytoplasm (Fig. 9Go). Identical results were obtained for SSB/La (data not shown). The finding that cardiocytes were not permeable to PI in the absence of prior fixation, but were stained by antisera containing SSA/Ro and SSB/La Abs under these identical conditions, further substantiated that an interaction with the target Ags occurs at the cell surface.



View larger version (133K):
[in this window]
[in a new window]
 
FIGURE 8. Cellular topology of SSA/Ro and SSB/La in nonpermeabilized nonapoptotic and apoptotic cultured human fetal cardiocytes. Living cultured cells were stained with human serum and subsequently fixed with 4% paraformaldehyde before counterstaining with PI. SSB/La and SSA/Ro were not detected in the cytoplasm or nucleus of living nonapoptotic cardiocytes (A and D, respectively). In contrast, both SSB/La and SSA/Ro were present in the periphery and surface blebs of apoptotic cardiocytes (B and E). A normal human serum did not stain nonpermeabilized nonapoptotic or apoptotic cardiocytes (G and H, respectively). Images were taken 5 h after induction of apoptosis with 0.5 µM staurosporine. Low power views of the nonpermeabilized apoptotic cardiocytes stained with anti-SSB/La (C), anti-SSA/Ro (F), or normal human serum (I) are shown for reference. Bar, 20 µm (A, C, D, F, G, I) or 10 µm (B, E, H).

 


View larger version (45K):
[in this window]
[in a new window]
 
FIGURE 9. SSA/Ro is found in blebs at the surface of nonpermeabilized apoptotic human fetal cardiocytes. A shows a three-dimensional composite using confocal microscope software of a nonpermeabilized apoptotic cardiocyte stained with anti-SSA/Ro and PI. The condensed nucleus is seen in red, and arrows point to the green blebs containing SSA/Ro. In B, a section through the middle of the cell shows the nucleus. Since the cells are not permeabilized, SSA/Ro is not detected. In C, a section through the apical surface of the cell shows three blebs stained with anti-SSA/Ro. Images were taken 6 h after induction of apoptosis with 0.5 µM staurosporine. Bar, 5 µm.

 
Since it has been reported that Abs can penetrate healthy living cells (42), thereby mediating cellular damage (43) and inducing apoptosis in some cell types (44), experiments were done to determine whether this mechanism could explain the pathogenic effect of anti-SSA/Ro and anti-SSB/La Abs in CHB. Nonapoptotic cultured human fetal cardiocytes were incubated with heat-inactivated serum containing anti-SSA/Ro and anti-SSB/La Abs, but no other known autoantibodies, and with normal human serum as control. Cells were observed under phase-contrast microscopy at various periods of time (2, 3, 5, 6, 8, 12, 24, 36, 48, 72, 96 h). No signs of apoptosis were observed at any time point and no autoantibody penetration into healthy living cardiocytes could be detected by indirect immunofluorescence (data not shown).


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Research efforts to define the molecular basis for the near-universal linkage of maternal anti-SSA/Ro-SSB/La Abs with CHB have yet to reconcile how these Abs interact with intracellular Ags and cause tissue damage. While specific maternal autoantibodies are probably necessary, they are not sufficient for development of cardiac disease. Apoptosis has been traditionally conceptualized from an immunologic point of view as either a means of maintaining B and T cell tolerance (45, 46) or as a mechanism by which sequestered cellular Ags elicit an immune response (28). It is the latter view of apoptosis that drives the hypothesis being tested in this study. However, in autoimmune-associated CHB, the newly accessible Ag is not inducing an immune response (i.e., immunogenic), but rather becomes a target of cognate maternal autoantibodies already present in the fetal circulation (i.e., antigenic). Characteristically, apoptosis occurs in isolated cells or groups of cells within a tissue, rather than affecting whole regions uniformly (31). Although apoptotic cells are usually eliminated at a rapid rate by phagocytes, circulating autoantibodies could immediately bind Ag and trigger an inflammatory response injurious to surrounding healthy myocytes. Indeed, Manfredi and colleagues have recently reported that anti-phospholipid Ab-opsonized apoptotic cells trigger a significantly greater release of the proinflammatory cytokine TNF-{alpha} from scavenger macrophages than that elicited by nonopsonized apoptotic cells (47, 48).

Apoptosis in the context of fetal disease is of interest since it is a selective process of physiologic cell deletion in embryogenesis and normal tissue turnover, and plays an important role in shaping morphologic and functional maturity (29, 30). In the normal adult myocardium, apoptosis has been observed only rarely (49, 50). In contrast, apoptosis does occur during cardiac development, a point relevant to neonatal lupus since the maternal heart is unaffected despite identical circulating autoantibodies (3). In the 1970s, Pexeider extensively characterized the temporal and spatial distribution of cell death in the hearts of chicken, rat, and human embryos (51). Major foci of apoptosis included the AV cushions and their zones of fusion, the bulbar cushions and their zones of fusion, and the aortic and pulmonary valves. Albeit much of the cell death was noted in nonmyocytes, a region of myocyte death was apparent in the muscular interventricular septum as it grew toward the AV cushions in midgestation. More recently, Takeda and colleagues demonstrated apoptosis in midgestational rat hearts using terminal deoxynucleotidyl transferase dUTP nick end labeling (31). It has also been suggested that apoptosis contributes to the postnatal morphogenesis of the sinus node, AV node, and His bundle (52). Although initial clinical detection of bradyarrhythmia is most often between 18 and 24 wk of gestation (6, 7, 53), progression of incomplete blocks after birth has been observed in several cases (53, 54). Moreover, a significant degree of myocyte apoptosis has been noted to occur in the right ventricle and interventricular septum of rats in the immediate postnatal period, which may contribute to right ventricular remodeling during the transition from fetal to adult circulations (55). Intractable cardiomyopathy, despite pacing, has been noted in several infants postpartum (53, 56).

The establishment of a reproducible high yield method for culturing human fetal cardiac myocytes was a requisite for the studies of apoptosis described in this work. The availability of cultured keratinocytes, the other most common target in neonatal lupus, has facilitated the identification of conditions that induce expression of SSA/Ro and SSB/La Ags and their translocation to the cell surface. We have applied the Langendorff technique to isolate cardiac myocytes and to subsequently maintain cells in culture. The presence of cardiac myocytes was confirmed by two independent assays. Contractility, after the addition of physiologic calcium and warming, assured that the cells were functionally viable cardiac myocytes. Staining with a mAb recognizing sarcomeric {alpha}-actinin was used to track the percentage of cardiac myocytes at different days in culture. Although the Langendorff technique has been used to obtain mammalian cardiac myocytes for patch clamping and recording of ion channels (25, 41), to our knowledge all published methods for the culturing of human fetal heart cells describe initial mechanical dispersion (minced pieces) of tissue, followed by incubation with various proteases (40, 57, 58, 59, 60, 61). Little information is provided on cell yields per heart for use in primary cultures. Cannulation of the aorta with subsequent perfusion of the heart via the coronary arteries facilitates greater accessibility of proteolytic enzyme to the tissue, thereby allowing a high cell yield since the majority of cells in a heart are dissociated and recovered. The isolation method we describe provides a constant O2 supply to all cells, which reduces the time of ischemia, thereby increasing cardiac myocyte viability. This is particularly important with regard to studies of apoptosis since ischemia can induce programmed cell death (49).

The physiologic triggers of apoptosis in fetal tissues are unknown. However, in general, all agents that induce apoptosis proceed through a common final pathway leading to identical characteristic morphologic and biochemical changes (28, 30). Available literature focuses on the role of cardiac apoptosis in myocardial infarction, with only scant data to provide guidelines for the study of apoptosis in the developing fetal heart. Krown has recently demonstrated that physiologically relevant levels of TNF-{alpha} and the endogenous second messenger, sphingosine, induce apoptosis in cultured adult rat ventricular myocardial cells (62). Neonatal rat ventricular cardiocytes are also driven into apoptosis when incubated with sphingosine. Curiously, TNF-{alpha} did not produce detectable apoptosis in the neonatal cells, most likely due to the absence of detectable levels of TNFR1. The authors conclude that both developing and terminally differentiated cardiac myocytes are susceptible to apoptosis, although possibly to different degrees and in response to different triggers. Other studies have demonstrated the induction of apoptosis in primary cultures of neonatal rat cardiocytes subjected to prolonged periods of hypoxia (63) and deprivation of glucose and serum (64). Tanaka et al. have demonstrated that hypoxia induces apoptosis with enhanced expression of Fas Ag mRNA in cultured neonatal rat cardiocytes (63). Kajstura et al. have reported that coronary artery occlusion of rat hearts resulted in increased expression of Fas (55). The rationale for use of two distinct approaches was that this work represented a first-time look at apoptosis of human fetal cardiocytes in culture, and it was not known whether susceptibility to apoptosis differed depending on the mode of induction. For example, HL-60 cells exhibit extreme sensitivity to UV irradiation, while K562 cells exhibit a high degree of resistance to UV irradiation (65). Initial experiments revealed that the serine/threonine protein kinase inhibitor, staurosporine, and the redox cycling quinone, DMNQ, both known to cause apoptosis in various cell types (66, 67, 68), were readily effective in cultured human fetal cardiocytes. In preliminary experiments by our group, no Fas or Fas ligand expression could be demonstrated by immunofluorescence on the surface of cultured human fetal cardiac myocytes, although Fas mRNA has been demonstrated previously in the murine heart (69).

Based on indirect immunofluorescence using human antisera, SSA/Ro and SSB/La Ags translocate from an intracellular location to the periphery and to blebs of apoptotic cultured human fetal cardiac myocytes. Our findings are comparable with those of Casciola-Rosen et al., who demonstrated that SSA/Ro and SSB/La ribonucleoproteins are clustered in surface blebs of keratinocytes that have undergone apoptosis in response to UV irradiation (28). These autoantigens are accessible to extracellular autoantibodies since specific human antisera stained the surface of nonfixed, nonpermeabilized apoptotic cardiocytes. No staining with sera containing anti-SSA/Ro or SSB/La was observed in control, nonapoptotic living cells. In permeabilized nonapoptotic human fetal cardiac myocytes, SSB/La is confined to the cell nucleus, while SSA/Ro is predominantly nuclear with minor cytoplasmic localization. The topology observed for SSA/Ro cannot be ascribed uniquely to 52- or 60-kDa SSA/Ro, given the human sera used for detection. The results for SSB/La are equivalent to those reported in other cell types (70, 71). The cellular localization of SSA/Ro has been discrepant in different studies, due in part to differences in fixation technique, human substrate, and the specificity of the Abs used for immunostaining. Most investigators have demonstrated predominantly nuclear and minor cytoplasmic localization for both the 52- and 60-kDa SSA/Ro Ags (19, 28, 72, 73, 74). One study found predominantly cytoplasmic localization of 60 and nuclear of 52 in HeLa and HEp-2 cells (75). In a recent study by Yell and colleagues using affinity-purified antisera, distinct differences were found between 52- and 60-kDa SSA/Ro, the former predominantly cytoplasmic and the latter nuclear (76). More recent work using mAbs reveals that both 52-kDa Ro and 60-kDa Ro are localized predominantly in the nucleus with some cytoplasmic staining, dependent on the cell type and fixation method (77, 78).

The findings reported herein apply to a mixed cardiocyte population, the majority of which are atrial and ventricular myocytes. Acknowledging that damage specific to the conducting system of the human fetal heart is characteristically associated with maternal anti-SSA/Ro-SSB/La Abs, it is anticipated that this novel culture system can be adapted for isolated SA and AV nodal cells. Several explanations, albeit each speculative, could account for the preferential vulnerability of the AV node. There may be a higher rate of apoptosis in this region, as suggested by the observations of Pexeider (51). The timing of transplacental passage of maternal autoantibodies may coincide with the period of maximal remodeling and apoptosis in the AV node. Phagocytosis of apoptotic cardiocytes by adjacent healthy cells or macrophages in the AV node could occur at a decreased rate relative to other areas of the heart. Perhaps there is a lower regenerative capacity of the AV node compared with the working myocardium. It has been described that fetal and neonatal, but not adult myocytes retain the capacity to divide, although there are no reports addressing this issue in conduction system or pacemaker cells.

Importantly, as more cases of autoimmune-associated CHB are reported and autopsies reviewed, it is clear that damage is not confined exclusively to the AV node. The working myocardium is also a target of injury. Mononuclear cell infiltration has been demonstrated in the myocardium of a fetus dying in utero at 18 wk of gestation (8), and patchy lymphoid aggregates were observed throughout the myocardium of an infant delivered at 30 wk and dying in the immediate postnatal period (79). Moreover, on postmortem analysis of neonates with CHB, immunofluorescence studies have demonstrated deposition of IgG and complement (including C1q, C4, C3, C6, and C9), not only in the conducting system (nodal tissue, bundle of His, and Purkinje’s fibers), but also in the working myocardium (79, 80, 81). Horsfall and colleagues showed deposition of anti-SSB/La Abs on the surface of myocardial fibers in fetal cardiac tissue of a stillborn (30 wk) with CHB, using polyclonal anti-idiotypic Abs (26). Extensive review of cases in the Research Registry for Neonatal Lupus (established in October 1994 and supported by funding from the National Institute of Arthritis and Musculoskeletal and Skin Diseases) confirms that myocardial dysfunction independent of bradycardia can be part of the spectrum of disease (53).

Although apoptosis could explain accessibility of intracellular Ags to circulating autoantibodies, the reasons for the selective vulnerability of specific fetal organs (heart, skin, liver), the low rate (1–2%) of disease in offspring of mothers with anti-SSA/Ro-SSB/La Abs, and discordance in monozygotic twins are not readily apparent. Undoubtedly, other fetal organs undergo apoptosis, but the timing relative to transplacental transport of maternal Abs and the degree have not been extensively studied. Alternatively, there may be subclinical injury to other organs, but repair occurs without sequelae. In utero injury during the mid-second trimester could well be more frequent than clinically apparent, but some fetuses might heal without permanent consequence or suffer lesser degrees of scarring. Autoimmune-associated CHB can be first, second, or third degree (53), and may or may not be progressive after detection in utero or postnatally (53, 54). Furthermore, individual differences in the immune mechanisms involved in Ab-mediated inflammatory responses, such as Fc{gamma}R polymorphisms or differences in the timing of NK cell, neutrophil, or macrophage maturation, could account for this.

In summary, the evidence reported supports the hypothesis that apoptosis of human fetal cardiocytes may be a means by which the intracellular SSA/Ro and SSB/La target Ags become accessible to circulating maternal autoantibodies. This work was accomplished by the development of a novel method for culturing human fetal cardiac myocytes. Although apoptosis does not readily account for all of the clues observed at the bedside, it may be one fetal factor among several that contribute to the pathogenesis of autoimmune-associated CHB.


    Acknowledgments
 
We thank Dr. Gerald Cohen for his gift of DMNQ, and Ann Rupel for assistance in preparation of the manuscript.


    Footnotes
 
1 This work was supported by National Institutes of Health Grant AR-42455 (to J.P.B.), by a grant from the S.L.E. Foundation, Inc. (to J.P.B.), and by a fellowship award from New York Chapter of the Arthritis Foundation (to M.E.M.). Back

2 Address correspondence and reprint requests to Dr. Jill P. Buyon, Department of Rheumatology, Room 1608, Hospital for Joint Diseases, 301 East 17th Street, New York, NY 10003. Back

3 Abbreviations used in this paper: CHB, congenital heart block; DMNQ, 2,3-dimethoxy-1,4-naphthoquinone; PARP, poly(ADP-ribose) polymerase; PI, propidium iodide. Back

Received for publication March 23, 1998. Accepted for publication June 24, 1998.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. McCue, C. M., M. E. Mantakas, J. B. Tingelstad. 1997. Congenital heart block in newborns of mothers with connective tissue disease. Circulation 56:82.[Abstract/Free Full Text]
  2. Chameides, L., R. C. Truex, V. Vetter, W. J. Rashkind, F. M. Galioto, J. A. Noonan. 1977. Association of maternal systemic lupus erythematosus with congenital complete heart block. N. Engl. J. Med. 297:1204.[Abstract]
  3. Buyon, J. P.. 1992. Neonatal lupus syndromes. R. Lahita, ed. Systemic Lupus Erythematosus 2nd ed.419. Churchill Livingstone, New York.
  4. Lee, L. A.. 1990. Maternal autoantibodies and pregnancy. II. The neonatal lupus syndrome. Baillieres Clin. Rheumatol. 4:69.[Medline]
  5. Buyon, J. P., R. Winchester. 1990. Congenital complete heart block: a human model of passively acquired autoimmune injury. Arthritis Rheum. 33:609.[Medline]
  6. Buyon, J. P., J. Waltuck, C. Kleinman, J. Copel. 1995. In utero identification and therapy of congenital heart block (CHB). Lupus 4:116.[Abstract/Free Full Text]
  7. Waltuck, J., J. P. Buyon. 1994. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann. Intern. Med. 120:544.[Abstract/Free Full Text]
  8. Herreman, G., N. Galezewski. 1985. Maternal connective tissue disease and congenital heart block. N. Engl. J. Med. 312:1329.[Medline]
  9. Buyon, J. P., S. Swersky, H. Fox, F. Bierman, R. J. Winchester. 1987. Intrauterine therapy for presumptive fetal myocarditis with acquired heart block due to systemic lupus erythematosus: experience in a mother with a predominance of SSB/La antibodies. Arthritis Rheum. 30:44.[Medline]
  10. Ben-Chetrit, E., B. J. Gandy, E. M. Tan, K. F. Sullivan. 1989. Isolation and characterization of a cDNA clone encoding the 60-kD component of the human SS-A/Ro ribonucleoprotein autoantigen. J. Clin. Invest. 83:1284.
  11. Deutscher, S. L., J. B. Harley, J. D. Keene. 1988. Molecular analysis of the 60kDa human Ro ribonucleoprotein. Proc. Natl. Acad. Sci. USA 85:9479.[Abstract/Free Full Text]
  12. Lerner, M. R., J. A. Boyle, J. A. Hardin, J. A. Steitz. 1981. Two novel classes of small ribonucleoproteins detected by antibodies associated with lupus erythematosus. Science 211:400.[Abstract/Free Full Text]
  13. O’Brien, C. A., S. L. Wolin. 1994. A possible role for the 60-kD Ro autoantigen in a discard pathway for defective 5s rRNA precursors. Genes Dev. 8:2891.[Abstract/Free Full Text]
  14. Chan, E. K. L., K. F. Sullivan, E. M. Tan. 1989. Ribonucleoprotein SS-B/La belongs to a protein family with consensus sequences for RNA-binding. Nucleic Acids Res. 17:2233.[Abstract/Free Full Text]
  15. Chambers, J. C., D. Kenan, B. J. Martin, J. D. Keene. 1988. Genomic structure and amino acid sequence domains of the human La autoantigen. J. Biol. Chem. 263:18043.[Abstract/Free Full Text]
  16. Boire, B., J. Craft. 1990. Human Ro ribonucleoprotein particles: characterization of native structure and stable association with the La polypeptide. J. Clin. Invest. 85:1182.
  17. Gottlieb, E., J. A. Steitz. 1989. Function of the mammalian La protein: evidence for its action in transcription termination by RNA polymerase III. EMBO J. 8:851.[Medline]
  18. Yoo, C. J., S. L. Wolin. 1997. The yeast La protein is required for the 3' endonucleolytic cleavage that matures tRNA precursors. Cell 89:393.[Medline]
  19. Ben-Chetrit, E., E. K. L. Chan, K. F. Sullivan, E. M. Tan. 1988. A 52 kD protein is a novel component of the SS-A/Ro antigenic particle. J. Exp. Med. 162:1560.
  20. Chan, E. K. L., J. C. Hamel, J. P. Buyon, E. M. Tan. 1991. Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen. J. Clin. Invest. 87:68.
  21. Itoh, K., Y. Itoh, M. B. Frank. 1991. Protein heterogeneity in the human Ro/SSA ribonucleoproteins. J. Clin. Invest. 87:177.
  22. Chan, E. K. L., F. DiDonato, J. C. Hamel, C. E. Tseng, J. P. Buyon. 1995. 52-kD SS-A/Ro: genomic structure and identification of an alternatively spliced transcript encoding a novel leucine zipper-minus autoantigen expressed in fetal and adult heart. J. Exp. Med. 182:983.[Abstract/Free Full Text]
  23. Alexander, E., J. P. Buyon, T. T. Provost, T. Guarnieri. 1992. Anti-Ro/SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model: in vitro electrophysiologic and immunocytochemical studies. Arthritis Rheum. 35:176.[Medline]
  24. Garcia, S., J. H. M. Nascimento, E. Bonfa, R. Levy, S. F. Oliveira, A. V. Tavares, A. C. Campos deCarvalho. 1994. Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts. J. Clin. Invest. 93:718.
  25. Boutjdir, M., L. Chen, Z. Zhang, C. Tseng, F. DiDonato, W. Rashbaum, A. Morris, N. El-Sherif, J. P. Buyon. 1997. Arrhythmogenicity of IgG and anti-52kD SSA/Ro affinity purified antibodies from mothers of children with congenital heart block. Circ. Res. 80:354.[Abstract/Free Full Text]
  26. Horsfall, A. C., P. J. W. Venables, P. V. Taylor, R. N. Maini. 1991. Ro and La antigens and maternal autoantibody idiotype on the surface of myocardial fibres in congenital heart block. J. Autoimmun. 4:165.[Medline]
  27. Reichlin, M., A. Brucato, M. B. Frank, P. J. Maddison, V. R. McCubbin, M. Wolfson-Reichlin, L. Lee. 1994. Concentration of autoantibodies to native 60-kd Ro/SS-A and denatured 52-kd Ro/SS-A in eluates from the heart of a child who died with congenital complete heart block. Arthritis Rheum. 37:1698.[Medline]
  28. Casciola-Rosen, L. A., G. Anhalt, A. Rosen. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179:1317.[Abstract/Free Full Text]
  29. Ucker, D. S.. 1991. Death by suicide: one way to go in mammalian cellular development?. New Biol. 3:103.[Medline]
  30. Hale, A. J., C. A. Smith, L. C. Sutherland, V. E. A. Stoneman, V. L. Longthorne, A. C. Culhane, G. T. Williams. 1996. Apoptosis: molecular regulation of cell death. Eur. J. Biochem. 236:1.[Medline]
  31. Takeda, K., Z. Yu, T. Nishikawa, M. Tanaka, S. Hosoda, V. J. Ferrans, T. Kasajima. 1996. Apoptosis and DNA fragmentation in the bulbus cordis of the developing rat heart. J. Mol. Cell. Cardiol. 28:209.[Medline]
  32. Langendorff, O.. 1895. Untersuchungen am überlebenden Saugertierherzen. Arch. Gesamte Physiol. Mens. Tiere Pflügers 61:291.
  33. McGahon, A. J., S. J. Martin, R. P. Bissonnette, A. Mahboubi, Y. Shi, R. J. Mogil, W. K. Nishioka, D. R. Green. 1995. The end of the (cell) line: methods for the study of apoptosis in vitro. Methods Cell Biol. 46:166.
  34. Kerr, J. F., G. C. GobJ, C. M. Winterford, B. V. Harmon. 1995. Anatomical methods in cell death. Methods Cell Biol. 46:22.
  35. Casiano, C. A., R. L. Ochs, E. M. Tan. 1998. Distinct cleavage products of nuclear proteins in apoptosis and necrosis revealed autoantibody probes. Cell Death Differ. 5:183.[Medline]
  36. Buyon, J. P., R. J. Winchester, S. G. Slade, F. Arnett, J. Copel, D. Friedman, M. D. Lockshin. 1993. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children: comparison of ELISA and immunoblot to measure anti-SSA/Ro and anti-SSB/La antibodies. Arthritis Rheum. 36:1263.[Medline]
  37. Casiano, C. A., S. J. Martin, D. R. Green, E. M. Tan. 1996. Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis. J. Exp. Med. 184:765.[Abstract/Free Full Text]
  38. Chan, E. K. L., E. M. Tan. 1987. Human autoantibody-reactive epitopes of SSB/La are highly conserved in comparison with epitopes recognized by murine monoclonal antibodies. J. Exp. Med. 166:1627.[Abstract/Free Full Text]
  39. Wright, S. J., V. E. Centonze, S. A. Stricker, P. J. DeVries, S. W. Paddock, G. Schatten. 1993. Introduction to confocal microscopy and three-dimensional reconstruction. Methods Cell Biol. 38:1.[Medline]
  40. Kohtz, D. S., R. Dische, T. Inagami, B. Goldman. 1989. Growth and partial differentiation of presumptive human cardiac myoblasts in culture. J. Cell Biol. 108:1067.[Abstract/Free Full Text]
  41. Tytgat, J.. 1994. How to isolate cardiac myocytes. Cardiovasc. Res. 28:280.[Free Full Text]
  42. Golan, T. D., A. E. Gharavi, K. B. Elkon. 1993. Penetration of autoantibodies into living epithelial cells. J. Invest. Dermatol. 100:316.[Medline]
  43. Vlakos, D., M. H. Foster, A. Ucci, K. J. Barrett, S. K. Datta, M. P. Madaio. 1992. Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei and induce glomerular proliferation and proteinuria in vivo. J. Am. Soc. Nephrol. 2:1345.[Abstract]
  44. Alarcon-Segovia, D., L. Llorente, A. Ruiz-Arguelles. 1996. The penetration of autoantibodies into cells may induce tolerance to self by apoptosis of autoreactive lymphocytes and cause autoimmune disease by dysregulation and/or cell damage. J. Autoimmun. 9:295.[Medline]
  45. Watanabe-Fukunaga, R., C. L. Brannan, N. G. Copeland, N. A. Jenkins, S. Nagata. 1993. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
  46. Bretscher, P.. 1992. The two-signal model of lymphocyte activation twenty-one years later. Immunol. Today 13:74.[Medline]
  47. Manfredi, A. A., P. Rovere, G. Galati, S. Heltai, E. Bozzolo, L. Soldini, J. Davoust, G. Balestrieri, A. Tincani, M. G. Sabbadini. 1998. Apoptotic cell clearance in systemic lupus erythematosus. I. Opsonization by antiphospholipid antibodies. Arthritis Rheum. 41:205.[Medline]
  48. Manfredi, A. A., P. Rovere, S. Heltai, G. Galati, G. Nebbia, A. Tincani, G. Balestrieri, M. G. Sabbadini. 1998. Apoptotic cell clearance in systemic lupus erythematosus. II. Role of ß2-glycoprotein I. Arthritis Rheum. 41:215.[Medline]
  49. Kajstura, J., W. Cheng, K. Reiss, W. A. Clark, E. H. Sonneblick, S. Krajewski, J. C. Reed, G. Olivetti, P. Anversa. 1996. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab. Invest. 74:86.[Medline]
  50. Cheng, W., B. Li, J. Kajstura, P. Li, M. S. Wolin, E. H. Sonneblick, T. H. Hintze, G. Olivetti, P. Anversa. 1995. Stretch-induced programmed myocyte cell death. J. Clin. Invest. 96:2247.
  51. Pexeider, T.. 1975. Cell death in the morphogenesis and teratogenesis of the heart. Adv. Anat. Embryol. Cell Biol. 51:1.[Medline]
  52. James, T. N.. 1994. Normal and abnormal consequences of apoptosis in the human heart: from postnatal morphogenesis to paroxysmal arrhythmias. Circulation 90:556.[Abstract/Free Full Text]
  53. Buyon, J. P., R. Hiebert, J. Copel, J. Craft, D. Friedman, M. Katholi, L. A. Lee, T. T. Provost, M. Reichlin, L. Rider, A. Rupel, S. Saleeb, W. Weston, M. L. Skovron. 1998. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J. Am. Coll. Cardiol. 31:1658.[Abstract/Free Full Text]
  54. Geggel, R. L., L. Tucker, I. Szer. 1988. Postnatal progression from second to third-degree heart block in neonatal lupus syndrome. J. Pediatr. 113:1049.[Medline]
  55. Kajstura, J., M. Mansukhani, W. Cheng, K. Reiss, S. Krajewski, J. C. Reed, F. Quaini, E. H. Sonnenblick, P. Anversa. 1995. Programmed cell death and the expression of the protooncogene bcl-2 in myocytes during postnatal maturation of the heart. Exp. Cell Res. 219:110.[Medline]
  56. Taylor-Albert, E., M. Reichlin, W. H. Toews, E. D. Overholt, L. A. Lee. 1997. Delayed dilated cardiomyopathy as a manifestation of neonatal lupus: case reports, autoantibody analysis and management. Pediatrics 99:733.[Free Full Text]
  57. Hassall, C. J., R. Penketh, C. Rodeck, G. Burnstock. 1990. The intracardiac neurones of the fetal human heart in culture. Anat. Embryol. 182:329.[Medline]
  58. Bkaily, G., A. Sculptoreanu, D. Jacques, D. Economos, D. Menard. 1992. Apamin, a highly potent fetal L-type Ca2+ current blocker in single heart cells. Am. J. Physiol. 262:H463.[Abstract/Free Full Text]
  59. Goldman, B., A. Mach, J. Wurzel. 1996. Epidermal growth factor promotes a cardiomyoblastic phenotype in human fetal cardiac myocytes. Exp. Cell Res. 228:237.[Medline]
  60. Goldman, B. I., J. Wurzel. 1992. Effects of subcultivation and culture medium on differentiation of human fetal cardiac myocytes. In Vitro Cell. Dev. Biol. 28A:109.
  61. Huang, M. H., D. S. Friend, M. E. Sunday, K. Singh, K. Haley, K. F. Austen, R. A. Kelly, T. W. Smith. 1996. An intrinsic adrenergic system in mammalian heart. J. Clin. Invest. 98:1298.[Medline]
  62. Krown, K. A., M. T. Page, C. Nguyen, D. Zechner, V. Gutierrez, K. L. Comstock, C. C. Glembotski, P. J. E. Quintana, R. A. Sabbadini. 1996. Tumor necrosis factor {alpha}-induced apoptosis in cardiocyte myocytes: involvement of the sphingolipid signalling cascade in cardiac cell death. J. Clin. Invest. 98:2854.[Medline]
  63. Tanaka, M., H. Ito, S. Adachi, H. Akimoto, T. Nishikawa, T. Kasajima, F. Marumo, M. Hiroe. 1994. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ. Res. 75:426.[Abstract/Free Full Text]
  64. Umansky, S. R., G. M. Cuenco, S. S. Khutzian, P. J. Barr, L. D. Tomei. 1995. Postischemic apoptotic death of rat neonatal cardiomyocytes. Cell Death Differ. 2:235.
  65. Martin, S. J., T. G. Cotter. 1991. Ultraviolet B irradiation of human leukemia HL-60 cells in vitro induces apoptosis. Int. J. Radiat. Biol. 59:1001.[Medline]
  66. Perandones, C. E., V. A. Illera, D. Peckham, L. Stunz, R. F. Ashman. 1993. Regulation of apoptosis in vitro in mature murine spleen T cells. J. Immunol. 151:3521.[Abstract]
  67. Dypbukt, J. M., M. Ankarcrona, M. Burkitt, A. Sjöholm, K. Ström, S. Orrenius, P. Nicotera. 1994. Different prooxidant levels stimulate growth, trigger apoptosis, or produce necrosis of insulin-secreting RINm5F cells. J. Biol. Chem. 48:30553.
  68. Clancy, R. M., S. B. Abramson, C. Kohne, J. Rediske. 1997. Nitric oxide attenuates cellular hexose monophosphate shunt response to oxidants in articular chondrocytes and acts to promote oxidant injury. J. Cell. Physiol. 172:183.[Medline]
  69. Watanabe-Fukunaga, R., C. I. Brannan, N. Itoh, S. Yonehara, N. G. Copeland, N. A. Jenkins, S. Nagata. 1992. The cDNA structure, expression and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148:1274.[Abstract]
  70. Chan, E. K. L., L. E. C. Andrade. 1992. Antinuclear antibodies in Sjögren’s syndrome. Rheum. Dis. Clin. North Am. 118:551.
  71. Alspaugh, M. A., N. Talal, E. M. Tan. 1976. Differentiation and characterization of autoantibodies and their antigens in Sjögren’s syndrome. Arthritis Rheum. 19:216.[Medline]
  72. Slobbe, R. L., G. J. M. Pruijn, W. G. M. Damen, J. W. C. M. Van der Keemp, W. J. Van Venrooij. 1991. Detection and occurrence of the 60- and 52-kD Ro (SS-A) antigens and of autoantibodies against these proteins. Clin. Exp. Immunol. 86:99.[Medline]
  73. Peek, R., W. J. van Venrooij, F. Simons, G. Pruijn. 1994. The SS-A/SS-B autoantigenic complex: localization and assembly. Clin. Exp. Rheumatol. 12:S15.
  74. Wahren, M., E. Mellqvist, S. Vene, N. R. Ringertz, I. Pettersson. 1996. Nuclear colocalization of the Ro 60 kDa autoantigen and a subset of U snRNP domains. Eur. J. Cell Biol. 70:189.[Medline]
  75. Kelekar, A., M. R. Saitta, J. D. Keene. 1994. Molecular composition of Ro small ribonucleoprotein complexes in human cells. J. Clin. Invest. 93:1637.
  76. Yell, J. A., L. Wang, H. Yin, D. P. McCauliffe. 1996. Disparate locations of the 52- and 60-kDa Ro/SS-A antigens in cultured human keratinocytes. J. Invest. Dermatol. 107:622.[Medline]
  77. Veldhoven, C. H., G. J. Pruijn, J. F. Meilof, J. P. Thijssen, A. W. Van der Kemp, W. J. Van Venrooij, R. J. Smeenk. 1995. Characterization of murine monoclonal antibodies against 60 kD Ro/SS-A and 48 kD La/SS-B autoantigens. Clin. Exp. Immunol. 101:45.[Medline]
  78. Schmitz, M., M. Bachmann, J. Laubinger, J. P. Thijssen, G. J. Pruijn. 1997. Characterization of murine monoclonal antibodies against the Ro52 autoantigen. Clin. Exp. Immunol. 110:53.[Medline]
  79. Lee, L. A., S. Coulter, S. Erner, H. Chu. 1987. Cardiac immunoglobulin deposition in congenital heart block associated with maternal anti-Ro antibodies. Am. J. Med. 83:793.[Medline]
  80. Taylor, P. V., J. S. Scott, L. M. Gerlis, F. R. C. Path, E. Esscher, O. Scott. 1986. Maternal antibodies against fetal cardiac antigens in congenital complete heart block. N. Engl. J. Med. 315:667.[Abstract]
  81. Litsey, S. E., J. A. Noonan, W. N. O’Connor, C. M. Cottrill, B. Mitchell. 1985. Maternal connective tissue disease and congenital heart block. N. Engl. J. Med. 312:98.[Medline]



This article has been cited by other articles:


Home page
J. Immunol.Home page
N. Calvani, R. Caricchio, M. Tucci, E. S. Sobel, F. Silvestris, P. Tartaglia, and H. B. Richards
Induction of Apoptosis by the Hydrocarbon Oil Pristane: Implications for Pristane-Induced Lupus
J. Immunol., October 1, 2005; 175(7): 4777 - 4782.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
N Costedoat-Chalumeau, S Georgin-Lavialle, Z Amoura, and J-C Piette
Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block
Lupus, September 1, 2005; 14(9): 660 - 664.
[Abstract] [PDF]


Home page
J. Immunol.Home page
L. Frisoni, L. Mcphie, L. Colonna, U. Sriram, M. Monestier, S. Gallucci, and R. Caricchio
Nuclear Autoantigen Translocation and Autoantibody Opsonization Lead to Increased Dendritic Cell Phagocytosis and Presentation of Nuclear Antigens: A Novel Pathogenic Pathway for Autoimmunity?
J. Immunol., August 15, 2005; 175(4): 2692 - 2701.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Qu, G. Baroudi, Y. Yue, and M. Boutjdir
Novel Molecular Mechanism Involving {alpha}1D (Cav1.3) L-Type Calcium Channel in Autoimmune-Associated Sinus Bradycardia
Circulation, June 14, 2005; 111(23): 3034 - 3041.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
J P Buyon, A Rupel, and R M Clancy
Neonatal lupus syndromes
Lupus, September 1, 2004; 13(9): 705 - 712.
[Abstract] [PDF]


Home page
Circ. Res.Home page
K. Hu, Y. Qu, Y. Yue, and M. Boutjdir
Functional Basis of Sinus Bradycardia in Congenital Heart Block
Circ. Res., March 5, 2004; 94 (4): e32 - e38.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Caricchio, L. McPhie, and P. L. Cohen
Ultraviolet B Radiation-Induced Cell Death: Critical Role of Ultraviolet Dose in Inflammation and Lupus Autoantigen Redistribution
J. Immunol., December 1, 2003; 171(11): 5778 - 5786.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. K. A. Mongini, A. E. Jackson, S. Tolani, R. J. Fattah, and J. K. Inman
Role of Complement-Binding CD21/CD19/CD81 in Enhancing Human B Cell Protection from Fas-Mediated Apoptosis
J. Immunol., November 15, 2003; 171(10): 5244 - 5254.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. Clancy, C. B. Backer, X. Yin, R. P. Kapur, Y. Molad, and J. P. Buyon
Cytokine Polymorphisms and Histologic Expression in Autopsy Studies: Contribution of TNF-{alpha} and TGF-{beta}1 to the Pathogenesis of Autoimmune-Associated Congenital Heart Block
J. Immunol., September 15, 2003; 171(6): 3253 - 3261.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
A Brucato, A Jonzon, D Friedman, L D Allan, G Vignati, M Gasparini, J I Stein, S Montella, M Michaelsson, and J Buyon
Proposal for a new definition of congenital complete atrioventricular block
Lupus, June 1, 2003; 12(6): 427 - 435.
[Abstract] [PDF]


Home page
J BiochemHome page
A. Shiratsuchi, T. Mori, Y. Takahashi, K. Sakai, and Y. Nakanishi
A Presumed Human Nuclear Autoantigen That Translocates to Plasma Membrane Blebs during Apoptosis
J. Biochem., February 1, 2003; 133(2): 211 - 218.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. Clancy, A. D. Askanase, R. P. Kapur, E. Chiopelas, N. Azar, M. E. Miranda-Carus, and J. P. Buyon
Transdifferentiation of Cardiac Fibroblasts, a Fetal Factor in Anti-SSA/Ro-SSB/La Antibody-Mediated Congenital Heart Block
J. Immunol., August 15, 2002; 169(4): 2156 - 2163.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
A D Askanase, D M Friedman, J Copel, M R Dische, A Dubin, T J Starc, M C Katholi, and J P Buyon
Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies
Lupus, March 1, 2002; 11(3): 145 - 151.
[Abstract] [PDF]


Home page
NeoReviewsHome page
J. P. Buyon, D. Nugent, E. Mellins, and C. Sandborg
Maternal Immunologic Diseases and Neonatal Disorders
NeoReviews, January 1, 2002; 3(1): e3 - 10.
[Full Text] [PDF]


Home page
FASEB J.Home page
G.-Q. XIAO, Y. QU, K. HU, and M. BOUTJDIR
Down-regulation of L-type calcium channel in pups born to 52 kDa SSA/Ro immunized rabbits
FASEB J, July 1, 2001; 15(9): 1539 - 1545.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G.-Q. Xiao, K. Hu, and M. Boutjdir
Direct Inhibition of Expressed Cardiac L- and T-Type Calcium Channels by IgG From Mothers Whose Children Have Congenital Heart Block
Circulation, March 20, 2001; 103(11): 1599 - 1604.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. S. Navratil, S. C. Watkins, J. J. Wisnieski, and J. M. Ahearn
The Globular Heads of C1q Specifically Recognize Surface Blebs of Apoptotic Vascular Endothelial Cells
J. Immunol., March 1, 2001; 166(5): 3231 - 3239.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M.-E. Miranda-Carus, A. D. Askanase, R. M. Clancy, F. Di Donato, T.-M. Chou, M. R. Libera, E. K. L. Chan, and J. P. Buyon
Anti-SSA/Ro and Anti-SSB/La Autoantibodies Bind the Surface of Apoptotic Fetal Cardiocytes and Promote Secretion of TNF-{alpha} by Macrophages
J. Immunol., November 1, 2000; 165(9): 5345 - 5351.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Xiao, J. He, R. D. Gilbert, and L. Zhang
Cocaine Induces Apoptosis in Fetal Myocardial Cells through a Mitochondria-Dependent Pathway
J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 8 - 14.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. Ayukawa, S.'i. Taniguchi, J. Masumoto, S. Hashimoto, H. Sarvotham, A. Hara, T. Aoyama, and J. Sagara
La Autoantigen Is Cleaved in the COOH Terminus and Loses the Nuclear Localization Signal during Apoptosis
J. Biol. Chem., October 27, 2000; 275(44): 34465 - 34470.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miranda, M. E.
Right arrow Articles by Buyon, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miranda, M. E.
Right arrow Articles by Buyon, J. P.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS